Revenue by Product

Fiscal year is January - December.

Year Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Drugs for Cancer Targeted Therapy and Immunotherapy	249.01M	Log In
Drugs for Cancer Targeted Therapy and Immunotherapy Growth	1275.13%	Log In

Revenue by Geography

Fiscal year is January - December.

Year Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
China	249.01M	Log In
China Growth	1275.13%	Log In